FGF2 and gastrointestinal stromal tumor: Conversely, siRNA-mediated knockdown of FGF2 re-sensitized GIST cells to imatinib, while increased protein levels of FGF2 were found in imatinib-resistant with respect to imatinib-sensitive GIST cells, a finding that was also confirmed in GIST patient samples [27].